ASC Reimbursement Strategies in Ophthalmology in 2026

Regulatory changes can be a strategic lever toward practice goals.

By: Rebecca Greenlaw, CPC, CPCO, COPC

Ophthalmology Management March 2, 2026 Vol 30, Issue The Ophthalmic ASC March 2026 Page(s): 3-6

Clinical Report: ASC Reimbursement Strategies in Ophthalmology in 2026

Overview

The finalized 2026 Medicare payment policies present both challenges and opportunities for ophthalmology ASCs. Key changes include a modest 2.4% payment increase and an expansion of the ASC Covered Procedures List, which may enhance case mix and profitability for practices that adapt effectively.

Background

The ambulatory surgery center (ASC) is crucial for the financial viability of ophthalmic practices, particularly for procedures like cataract and glaucoma surgeries. Understanding the evolving reimbursement landscape is essential for ophthalmology groups to maintain operational efficiency and patient access. The 2026 Medicare updates reflect a significant shift towards aligning ASC and hospital outpatient department payment systems, emphasizing the need for strategic adaptation.

Data Highlights

No numerical data provided in the article.

Key Findings

CMS's 2026 updates include a 2.4% payment increase for ASC facility services.
Several ophthalmic procedures are newly eligible for ASC payment, enhancing case migration opportunities.
Ophthalmology ASCs have a strong safety record, supporting the shift of more procedures from HOPDs.
ASCs perform ophthalmic procedures at 40% to 60% lower costs than HOPDs.
Practices must prepare for new procedures by evaluating anesthesia protocols and staff training.
Changes in the Medicare Physician Fee Schedule may impact reimbursement for commonly performed CPT codes.

Clinical Implications

Ophthalmology practices should proactively assess the implications of the 2026 Medicare updates on their operations and reimbursement strategies. By preparing for the expansion of the ASC Covered Procedures List, practices can enhance their case mix and financial performance while ensuring compliance with new administrative requirements.

Conclusion

The 2026 Medicare updates present a pivotal moment for ophthalmology ASCs, offering opportunities for improved reimbursement and operational efficiency. Strategic adaptation to these changes will be essential for maintaining financial stability and patient access.

PentaVision

Ophthalmology Management